New Magic Mushrooms Could Fix Depression, Addiction, Epilepsy, and More

Kozikowski and his company, Bright Minds Biosciences, have picked up Hoffman’s discarded thread, dusting off 50-year-old pharmacology shunted aside by the drug war. A retired professor in medicinal chemistry at the University of Illinois at Chicago, Kozikowksi has patented several compounds that are similar to psychedelic mushrooms, but don’t activate the 5-HT2B receptor, as mushroom-derived psilocybin will do.

Leave a Reply

Your email address will not be published. Required fields are marked *